Verge Genomics

Verge

This company provides a technology platform using artificial intelligence and human genomics to discover and develop drugs for patients with neurodegenerative diseases.

Generate Biomedicine

This company develops protein-based therapeutics using a generative artificial intelligence platform for pharmaceutical partners and biotechnology firms.

Nygen

This company develops cloud-based data platforms that use artificial intelligence to analyse and interpret single-cell genomic datasets for pharmaceutical and academic research teams.

Sensorium Therapeutics

This biotech company develops central nervous system therapies for patients with anxiety, epilepsy and neurodegenerative diseases using a machine learning drug discovery platform.

CircNova

This biotechnology company develops an artificial intelligence platform to design circular RNA therapeutics for biopharmaceutical partners to treat cancer and neurodegenerative diseases.

Creyon Bio

This company develops AI-designed oligonucleotide-based medicines and RNA-targeted therapies for pharmaceutical partners and patients with neuromuscular and immunological diseases.

CoSyne Therapeutics

The company develops artificial intelligence platforms to discover precision medicines for patients with brain cancer and neurological conditions.

Exin Therapeutics

This company develops an artificial intelligence platform to discover and design neurotherapeutics targeting neural circuits for patients with neurological and neuropsychiatric disorders.